SCSiddharth Chavali

Siddharth Chavali

*This is an algorithmically generated author record based on publicly available information.

Siddharth Chavali has a total of 30 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Management of Cerebral Vasospasm after Aneurysmal Subarachnoid Hemorrhage: An Update

    by Siddharth Chavali, Jayanth R. Seshan, Girija P. Rath

    Cerebral vasospasm is one of the major complications of aneurysmal subarachnoid hemorrhage (aSAH). The term vasospasm generally refers to angiographical findings, and clinically is defined by delayed neurological deterioration and delayed cerebral ischemia. Symptomatic vasospasm occurs in 20 to 40% of aSAH patients and is one of the least understood components of management. Diagnosis can be made clinically by using bedside modalities and radiography. Management begins with the use of preventive modalities, augmentation of cerebral perfusion, attempts at reversal, and the use of brain protection. Early use of endovascular therapy with mechanical or pharmacological angioplasty remains a reasonable approach. Of proven benefit are the use of cerebral vasodilators such as nimodipine and milrinone and the use of induced hypertension for cerebral perfusion augmentation. Agents for the spasmogenic blockade, inhibition of smooth muscle contraction, and brain protection remain largely experimental. This narrative review aims to update readers on the mechanism, diagnosis, prevention, and management of vasospasm in aSAH.

  • Open Access

    Precision in Anesthesia for Awake Craniotomies: Confronting Surgical Challenges

    by Siddharth Chavali, Girija P. Rath

    Awake craniotomy has significantly impacted neurosurgical procedures, particularly for operations that necessitate maximal preservation of neurological functions.[1] This technique, which involves the patient being awake during the surgery, requires a sophisticated approach to anesthetic management, combining a deep understanding of neurophysiology with the ability to navigate the unique challenges presented by individual pathologies.[2] Recent advancements in technology and anesthetic techniques have further refined awake craniotomy, making it a more viable option for a wider range of patients. This editorial aims to dissect the recent literature, integrating insights into anesthetic strategies, patient safety, and multidisciplinary collaboration to provide a comprehensive view of the evolving landscape of the procedure. Thakkar and colleagues performed a comparative analysis between propofol and dexmedetomidine, two primary sedatives during awake craniotomy.[3] The study illuminates the differential impacts of these agents on intraoperative neurological assessment and patient comfort. While both have proven effective, their use must be tailored to individual patient characteristics and surgical demands. The article importantly underscores the need for larger, prospective trials to establish more robust, evidence-based protocols for sedation in awake craniotomy. Such research is crucial for advancing our understanding of how to utilize sedatives best, balancing the need for patient cooperation with the necessity of minimizing neurological interference and ensuring patient safety. Shah and colleagues[4] performed a nuanced case study of awake craniotomy for cerebral abscess in a patient with a pulmonary arteriovenous malformation (PAVM), a complex condition that significantly impacts anesthetic management. PAVMs are associated with the risks of hypoxemia and paradoxical embolism, particularly under general anesthesia (GA). Hence, awake craniotomy in this scenario was chosen as an alternative anesthetic technique with the objective of reducing perioperative complications. While “conscious sedation (CS)” or “monitored anesthesia care (MAC)” with moderate sedation could be the technique of choice in such a complex medical scenario, the “asleep-awake-asleep (AAA) technique” with GA as one of the components may not be helpful. Moreover, Shah et al discuss a tailored approach to sedation and analgesia, emphasizing the need for a comprehensive understanding and management of the unique pathophysiological aspects of PAVMs. It highlights the importance of meticulous preoperative planning, including hydration, antibiotic prophylaxis, and strategies to mitigate the risks associated with GA. This case study serves as a crucial reminder of the importance of individualized anesthetic planning and the anesthesiologist's role in managing complex cases, ensuring patient safety, and achieving optimal surgical outcomes. The article “Awake aneurysm clipping: challenges conquered” by Kaur and colleagues[5] focuses on the challenges and strategies involved in conducting an awake craniotomy for aneurysmal clipping. The article underscores the complexities of maintaining an adequate level of sedation that allows for patient interaction and immediate neurological assessment while preventing pain and anxiety. The use of multimodal analgesia, vigilant monitoring of neurological status, and employing a supportive, patient-centered approach are discussed as key strategies for managing these high-risk procedures. The narrative highlights the critical role of anesthesiologists in navigating the delicate balance between sedation and patient engagement, illustrating the demanding yet rewarding nature of awake craniotomy in intracranial aneurysmal surgery. Several key themes emerge from the synthesis of these articles. First, the anesthetic management of awake craniotomies is highly nuanced, requiring a profound understanding of pharmacological agents and their effects on neurological function.[6] Anesthesiologists must be skilled at tailoring their approach to the individual patient, considering the specific surgical requirements and the patient's medical and psychological profile. Second, the management of complex neurosurgical conditions presents unique challenges, demanding not only technical expertise but also a comprehensive understanding of the underlying pathophysiology and a proactive, patient-centered approach to care.[7] Additionally, the importance of multidisciplinary collaboration is paramount, involving neurosurgeons, anesthesiologists, neurophysiologists, and nursing staff in the planning and execution of awake craniotomies. To summarize, awake craniotomy is a dynamic and evolving field that requires anesthesiologists to remain at the forefront of innovation and education. By embracing a nuanced, evidence-based approach to anesthetic management, anesthesiologists can significantly contribute to the success of this procedure, enhancing patient safety, optimizing neurological outcomes, and expanding the boundaries of neurosurgery. Future directions for awake craniotomy involve exploring more about patient safety, improving surgical outcomes, and investigating novel anesthetic agents and techniques. As we continue to navigate the complexities of awake craniotomy, our commitment to innovation, patient-centered care, and continuous learning will guide us toward ever-higher standards of care in neuroanesthesia, reflecting the relentless pursuit of excellence in patient care and the critical role of anesthesiology in achieving this goal. As technology advances and our understanding deepens, awake craniotomy will continue to evolve, offering new possibilities and hope for patients requiring complex neurosurgical interventions. Article published online: 23 February 2024 © 2024. The Author(s). This is an open access article published by Thieme under the...

  • Open Access

    Emergency Neurosurgery in a Patient with a Large Thoracic Aortic Aneurysm: Sitting on a Bomb

    by Vyshnavi Lingareddy, Sameera Vattipalli, Siddharth Chavali, Suresh Kanasani, Subodh Raju

    Thoracic aortic aneurysms larger than 5 cm are associated with a fatal risk of rupture, and their diagnosis is usually followed by urgent surgical repair. Other complications associated with this condition include heart failure, myocardial infarction, and stroke. Literature regarding management of these patients for emergency noncardiac surgeries is scarce, with anecdotal reports advising both surgeries in the same sitting. However, neurosurgical procedures present a unique challenge in this situation, since systemic anticoagulation may be associated with a rebleed within the cranial vault. In this case report, we present an extremely rare and challenging scenario, wherein a patient with a 6.2-cm thoracic aortic aneurysm underwent subdural hematoma evacuation prior to aneurysmal repair.

  • Open Access

    Management of a Patient with Bombay Blood Group and Chronic Liver Disease with Subdural Hematoma

    by Siddharth Chavali, Subodh Raju, Suresh Kanasani, Abhirama C. Gabbita

    The Bombay blood group is an extremely rare entity within the conventional ABO blood grouping system. End-stage liver disease also presents with myriad disorders of coagulation due to impaired synthesis and dysfunction of clotting factors, which predisposes patients to spontaneous and life-threatening episodes of bleeding. We report a patient with Bombay blood group and end-stage liver disease who presented to our hospital with a spontaneous subdural hematoma. Although conventional parameters of coagulation in this patient were abnormal, we were able to safely defer product transfusion because his thromboelastography (TEG) report was within acceptable ranges. In this article, we discuss our strategy for optimization of extremely limited blood resources in this scenario and perioperative strategies for the management of coagulation anomalies in patients with liver dysfunction.

  • Anesthesia for Craniopagus Separation Surgery

    by Girija Prasad Rath, Siddharth Chavali, Ritesh Lamsal, Deepak Gupta

  • Monitoring Children Undergoing Neurosurgery

    by Siddharth Chavali, Charu Mahajan, Girija Prasad Rath

  • Open Access

    Paroxysmal Sympathetic Hyperactivity: Ignoring the Presence of an Elephant in the Room

    by Parmod K. Bithal, Siddharth Chavali

    Paroxysmal sympathetic hyperactivity (PSH) is a syndrome of excessive and pathological adrenergic output to nociceptive or non-nociceptive (including environmental) stimuli. It is observed as a complication of various acute brain insults such as traumatic brain injury (TBI), stroke, anoxic brain injury, tumors, infections, autoimmune encephalitis, and acute hydrocephalus. It can manifest as a constellation of episodic, simultaneous symptoms such as tachycardia, hyperthermia, hypertension, tachypnea, and diaphoresis, often accompanied by dystonia and even motor posturing.[1] Onset of these symptoms is usually fast, but resolution is slow, unless terminated by medication. Since the first description of this syndrome by Penfield,[2] many names have been ascribed to it which has created puzzlement in its diagnosis as well as understanding of its pathophysiology. Some of the names associated with this condition over the years are “autonomic storm,” “sympathetic storm,” “hypothalamic dysregulation syndrome,” and “paroxysmal autonomic instability with dystonia.” In 2014, the International Brain Injury Association proposed the term “paroxysmal sympathetic hyperactivity.”[3] Its overall incidence is 18% among various cohorts of patients admitted in neurocritical care with an incidence of 33% in severe TBI patients.[4] According to Perkes et al, 80% of cases of PSH are observed after TBI, and the remaining 20% following other cerebral pathologies.[5] The most consistent observation is that patients with PSH are frequently young and comatose. Pediatric patients appear more prone to develop PSH after anoxic–ischemic insults and with non-bacterial encephalitis.[6] It is common that patients with PSH are erroneously suspected of having other diagnoses, and this may lead to unnecessary testing and sometimes inappropriate treatments, making an early and accurate diagnosis important.[7] PSH may persist for weeks or months, and has been associated with worse clinical outcomes such as increased time of mechanical ventilation, infection, malnutrition, dehydration, tracheostomy, longer hospitalization longer intensive care unit (ICU) stays, contractures, and heterotopic ossification. PSH remains an under-recognized condition that is difficult to diagnose. A high index of suspicion is key to early diagnosis. The first step in diagnosis is to exclude conditions with similar symptoms, such as infection, sedation withdrawal, seizures, and pulmonary embolism. Clinical diagnostic tools (PSH assessment measure) have been proposed to assist clinicians in the reliable identification of PSH.[8] Such tools incorporate a clinical feature scale that categorizes the severity of sympathetic signs during episodes and a diagnostic tool that gauges the likelihood of diagnosis of PSH based on the presence of characteristic features. These two components are combined in a score that reflects the degree of confidence in diagnosis of PSH. The feasibility and reliability of these tools have been recently validated by van Eijck et al.[9] There is evidence that they may reduce the chances of misdiagnosis and favorably impact hospital length of stay and costs of hospitalization.[10] The pathophysiology of PSH is poorly understood and the dominant theory suggests the failure of the central autonomic network. Disruption of descending pathways releases sympathetic responses from their normal inhibitory modulation. The consequence is that sympathetic responses to internal or external stimuli become exaggerated.[11] The interruption of descending inhibitory modulation might also produce maladaptive changes in the spinal cord leading to excitatory interneuronal activity.[12] These changes could help explain how non-noxious stimuli are perceived as noxious by brain.[12] While formal evidence on treatment is scant and lacks methodological quality, PSH is a disorder that can be treated.[13] Can episodes be prevented with pharmacological intervention? There is at least one retrospective study that claims so. Tang et al asserted that dexmedetomidine infusion has preventive effect on PSH in severe TBI patients who have undergone surgery.[14] Treatment revolves around meticulous general care and pharmacological therapy with abortive (morphine) and preventive medication (propranolol). Many other drugs have been used with varying success rates. Drug combinations are frequently used and chosen based on individual preference rather than objective evidence. Avoidance of triggering stimuli is critical in its management. While there are numerous published studies from various countries to unravel the epidemiology, pathophysiology, and management of this serious but treatable condition, in India, neurocritical care specialists are still under-recognizing/under-reporting this complication. Failure to recognize the condition can adversely impact outcomes of these patients. Literature search in Indian context revealed a few case reports but only one small study on PSH incidence in 57 patients admitted in neurological ICU by Verma et al in 2015, in which the authors reported 10.53% incidence of PSH.[15] In this issue of Journal of Neuroanesthesiology and Critical Care, Bhardwaj et al have published a retrospective study in a relatively large population of 257 patients with TBI, and have observed PSH in 30.8% of patients.[16] This study focuses only on patients with TBI, which raises questions regarding the true incidence of PSH in other varieties of critical neurological diseases. Hence, to validate their reported incidence of PSH, there is a crucial need for conducting prospective multicenter studies in the whole gamut of neurocritical care patients. This would expand the understanding of this condition among neurocritical care specialists with proper management and improved outcomes. A greater effort should also be devoted to discover pharmacological agents that can either prevent this...

  • Open Access

    Perioperative Challenges during Emergency Spine Surgery in a Patient with Right Atrial Thrombus

    by Siddharth Chavali, Ruhi Mamualiya, Hirok Roy, Girija P. Rath

    A 50-year-old male patient, weighing approximately 60 kg, presented with a history of excruciating lower back pain of 12 hours’ duration, associated with acute loss of bladder and bowel control. This was preceded by approximately a month of progressively increasing weakness in both lower limbs. Three years ago he underwent radical cystoprostatourethrectomy for carcinoma of the urethra. An emergency computed tomographic (CT) scan of the spine revealed a compression fracture of the thoracic (T10) vertebra. A diagnosis of malignant compressive fracture was made. In view of acute presentation of cauda equina syndrome, an urgent surgical decompression and fixation was planned. The patient was awake and alert, and oriented to time, place and person. Vitals were within normal ranges, and all hematological investigations were found to be within normal limits. Considering the history of progressive paraplegia given by the patient, we considered it prudent to perform a screening 2D echocardiogram as well as a lower limb color Doppler examination. Lower limb imaging was unremarkable for any pathology; however, echocardiography revealed a thrombus originating from the inferior vena cava, extending into the right atrium, which was approximately 3.5 × 3.2 × 2.9 cm in size ([Fig. 1]). Left ventricle was found to be normal, with preserved ejection fraction, and all valves were seen to be within normal limits. We were greatly concerned with regard to the safe induction and maintenance of anesthesia, especially since the surgery was to be performed in the prone position with the thrombus in situ. The patient was volume loaded with 500 mL of colloid and one liter of crystalloid. The left radial artery was cannulated prior to induction, and anesthesia was induced slowly with a regimen of etomidate, fentanyl, and rocuronium. This was followed by central venous cannulation which was uneventful. The patient was carefully turned prone, and the surgery proceeded uneventfully. At the end of the procedure, which lasted 3 hours, the patient was turned supine, and the trachea was extubated after reversal of residual neuromuscular blockade. The remainder of his hospital stay was uneventful, and he was advised to undergo mechanical thrombectomy. Deep venous thrombosis and pulmonary embolisms are complications frequently seen in patients who sustain high-cervical spinal cord trauma. Various measures to prevent their occurrence have been suggested, which include pneumatic compression, treatment with low-molecular weight heparin, inferior vena cava filter placement, etc.[1] [2] In this particular case, the emergent nature of the surgery precluded the use of any such measure. Moreover, the risk-benefit ratio of the surgery remains debatable, given the presentation of the patient with the above-mentioned scenario. The patient and relatives, in the presence of the operating team, were explained in detail, and necessary consent was taken. It would have been ideal had the patient undergone emergency mechanical thrombectomy prior to the definitive surgery which is also of emergent nature. It also suggested the fact that this particular scenario might help respective healthcare personnel plan surgery in resource-constrained situations. We would like to re-emphasize that patients presenting with cauda equina syndrome should be asked carefully regarding the duration of symptoms; and those with a history of paraparesis should undergo routine screening echocardiograms to rule out venous thromboembolism. Meticulous planning and careful management of intravascular volume status and hemodynamics may help patients overcome complications, in case the preventive/ definitive measures for subsequent thromboembolism are not available. Publication Date: 02 September 2020 (online) © . Thieme Medical and Scientific Publishers Private Ltd. A-12, Second Floor, Sector -2, NOIDA -201301, India

  • Open Access

    Transoral Neurosurgery during COVID-19 Pandemic

    by Siddharth Chavali, Vanitha Rajagopalan, Kanwaljeet Garg, Girija P. Rath

    The novel coronavirus (SARS-CoV-2) is a highly transmissible respiratory pathogen that causes coronavirus disease 2019 (COVID-19); recently, it has grown into a global pandemic.[1] During this period, patients requiring emergent as well as elective surgeries for craniovertebral junction (CVJ) pathologies present a unique challenge to the treating team, as they provide the potential to spread the infection to the health care workers (HCWs). The majority of patients infected with the virus are asymptomatic, and viral load has been seen to be greatest in the nasal cavity, nasopharynx, oropharynx, and lower respiratory tract even in asymptomatic patients.[2] Approach to CVJ lesions is determined by the nature of compression ([Fig. 1]). When dynamic radiological imaging shows the presence of reducible atlantoaxial dislocation, posterior instrumentation alone after reduction of dislocation may be adequate. Some cases of irreducible atlantoaxial dislocation can be dealt with the DCER technique, which involves distraction, compression, extension, and reduction. It is a posterior-only single-stage approach and may be considered as an alternative method.[3] However, a considerable number of these patients will still require anterior decompression in the form of transoral odontoidectomy. Indications of transoral odontoidectomy in today’s era include patients who have failed posterior fixation, pathologies with irreducible anterior compression along with compression of the cervicomedullary spinal cord, and patients with significantly deformed joints. Transoral odontoidectomy involves exposure of the CVJ through the oropharynx and the use of high-speed drills through the oropharyngeal exposure. Both these steps may expose HCWs to an increased risk of aerosol and droplet contamination.[4] Virus particles may remain airborne for over 3 hours, and such surgeries are considered high-risk procedures. These patients should be screened with questionnaires, chest X-rays, and test for COVID-19 regardless of risk status prior to admission and surgery, with the aim of minimizing length of hospital stay in patients who tested negative. Surgery should be deferred until patients test negative for COVID-19 if feasible since such surgeries are usually elective in nature, and patients who require urgent surgery should be considered COVID-19-positive until proven otherwise. For these patients, full personal protective equipment (PPE) should be donned by the operating team, given the increasing community prevalence of asymptomatic patients. The use of power drills should be minimized as far as possible to decrease aerosol generation. Generous irrigation may be helpful in mitigating aerosol generation to some extent, which results from the use of power drills, but should be performed carefully so as to avoid spilling of the saline outside the patient’s oral cavity. Irrigation of the surgical site with a diluted solution of povidone-iodine may also be considered since such solutions have been previously shown to rapidly inactivate coronaviruses.[5] Use of an operating microscope can be of help as the distance between the surgeon and the oropharynx increases considerably. The use of an endoscope may let the surgeon use a face shield while operating, which is not possible while using an operating microscope. Considerations for the anesthesia team include management of a potentially difficult airway, minimizing neck movement to prevent spinal cord compression, and minimizing exposure to aerosols during procedures such as intubation. Awake fiberoptic bronchoscopy is considered to be the gold standard for airway management in such patients; however, this procedure entails the risk of patient coughing and may be considered a high-risk procedure. Awake fiberoptic intubation should be avoided unless considered absolutely essential, and operators should don full PPE while minimizing the number of people in the operating theater during the procedure. Videolaryngoscopy under anesthesia may be favored to increase the distance between the airway operator and the patient and may optimize the chance of first-pass success, and application of manual in-line stabilization may help minimize excessive movement and cord compression during airway instrumentation.[6] Periprocedural briefings including a clearly communicated plan might help improve procedural safety. Management of the difficult airway requires expert operators, and protocolized approaches to preparation, procedures, and debriefings to minimize confusion and cognitive loading during a stressful situation. Postoperatively, such patients are usually ventilated electively since there is a significant degree of airway edema due to mucosal trauma following surgery. Care needs to be taken to ensure resolution of airway edema prior to extubation, and the cuff leak test may be inappropriate in patients who are confirmed COVID-19-positive. Appropriate PPE should be donned prior to extubation, and staff exposure should be minimized, ensuring that adequate steps are taken to minimize coughing and spread of aerosol droplets. Publication Date: 05 August 2020 (online) © . Thieme Medical and Scientific Publishers Private Ltd. A-12, Second Floor, Sector -2, NOIDA -201301, India

  • Open Access

    The Neurocritical Care Society of India (NCSI) and the Indian Society of Neuroanaesthesiology and Critical Care (ISNACC) Joint Position Statement and Advisory on the Practice of Neurocritical Care during the COVID-19 Pandemic

    by Ponniah Vanamoorthy, Gyaninder P. Singh, Prasanna U. Bidkar, Ranadhir Mitra, Kamath Sriganesh, Siddharth Chavali, Radhakrishnan Muthuchellapan, Venkatesh H. Keshavan, Saurabh Anand, Keshav Goyal, et al.

    The COVID-19 pandemic caused by severe acute respiratory syndrome coronavirus (SARS-CoV-2) has rapidly spread across the world including India. Management of patients complicated with neurological illness requiring neurocritical care is challenging during this time. Patients with neurological disease may develop COVID-19 infection or there could be independent neurological manifestations of COVID-19. Critically ill neurological patients are more vulnerable to contracting SARS-CoV-2 infection. Also, neurological patients with comorbidities and multisystem involvement are at increased risk of adverse outcomes. Though SARS-CoV-2 predominantly affects the pulmonary system, it can complicate the assessment and management of neurological patients. With increasing COVID-19 numbers, the hospitalizations of both non-COVID and COVID-19 neurological patients will bring significant strain on the hospital and neurocritical care facilities. Streamlining work pattern, understanding the pathophysiology of COVID-19 and its impact on neurological function, establishing general and specific neurocritical care management strategies, ensuring protection and well-being of health care providers, and implementing effective infection control policies are key elements of efficient neurocritical care management during this pandemic. This joint position statement and advisory on the practice of neurocritical care during the COVID-19 pandemic by the Neurocritical Care Society of India and the Indian Society of Neuroanaesthesiology and Critical Care has been developed to guide clinicians providing care to the critically ill neurological patients in the neurocritical care unit during the current pandemic. As the situation from this novel disease is rapidly evolving, readers must constantly update themselves with newly emerging evidence to provide the best possible care to the critically ill neurological patients.